June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

January 24, 2017

Cholesterol Therapies Could Slow Tumor Growth in Melanoma Patients with BRAF V600E Mutation

News

Cancer cells usually rely on blood sugar to grow, but melanomas with the BRAF V600E mutation prefer burning fat to get their energy, even when glucose is abundant. Although this ... Read more

January 19, 2017

Banning Minors from Indoor Tanning Could Save Thousands of Lives, $343M in Treatment Costs

News

Tanned skin may look appealing to some, but turning to tanning beds might not be a good idea — especially in teens or younger children. Recent findings from the Centers for Disease ... Read more

January 17, 2017

Immune Cells Delivered Drugs Specifically to Tumors in Lab Study

News

Using immune cells as carriers for nanoparticle-containing anti-cancer drugs may be a promising strategy to develop targeted therapies that affect tumor cells without damaging healthy cells. Indeed, loading immune cells ... Read more

January 12, 2017January 12, 2017

Northeast Seen to Have Greatest Drop in Melanoma Cases in US Between 2003-13

News

Investigators looking at changes in melanoma cases and death rates, reported in U.S. states and regions between 2003 and 2013, found that these rates varied widely among states — while some saw their numbers decrease, others ... Read more

January 10, 2017

Experimental Compound Has Great Potential to Prevent Melanoma Metastases

News

Researchers have identified a compound that could prevent malignant melanoma cells from spreading throughout the body. If the compound is successfully developed into a human drug, it has the potential ... Read more

January 3, 2017

X Chromosome Study Explores Why Melanoma is More Deadly for Men

News

Men who develop melanoma are twice as likely to die from the disease as women, but the molecular mechanisms involved in such disparity remain largely unknown. Now, researchers have pinpointed ... Read more

December 22, 2016

Partners Should Be Trained to Check for Mole Irregularities

News

A new study from Northwestern Medicine shows the advantages of partners frequently checking for potentially dangerous moles, after receiving training to do so. The study, “Self-confidence and Embarrassment About Partner-Assisted Skin ... Read more

December 20, 2016

Treatment Blocking Melanoma Metastasis May Be on the Horizon

News

A treatment preventing cancer metastases may become a reality within a decade, as researchers pinpointed a molecule driving metastasis formation in several cancers, including malignant melanoma. But the findings also ... Read more

December 15, 2016

P15 Protein Levels Could Help Doctors Distinguish Melanoma from Benign Moles

News

Researchers have found that a protein, called p15, may be used as a biomarker to distinguish melanoma from nevi (non-cancerous moles in the skin). Loss of this protein, which inhibits nevus ... Read more

December 13, 2016December 13, 2016

Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

News

Alcohol consumption is associated with a moderate increase in the risk of developing melanoma, according to the findings of a recent study published in the Cancer Epidemiology, Biomarkers & Prevention, a ... Read more

December 2, 2016

Melanoma’s Signature, Disease Development Controlled by CPEB4 Protein, Study Finds

News

Researchers have identified a protein called CPEB4 that seems to be crucial in establishing melanoma’s intrinsic signature and in driving the development of these aggressive tumors. The study, “Lineage-specific roles ... Read more

November 29, 2016November 29, 2016

Virtual Clinical Trial Model Seen to Predict Real Responses of Melanoma Patients to Therapies

News

Researchers with Moffitt Cancer Center developed a computational framework that, they say, can accurately predict patient responses to cancer treatments in a virtual clinical trial, called phase i. This new methodology integrates actual patient ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group